Pages

Saturday, May 21, 2022

PGA: Tiger Woods Withdraws After Third Round — May 21, 2022

Fourth round: watching the early morning players, many playing +10 and more, perhaps more should follow Tiger's lead and simply withdraw after the third round, or better yet, have a second cut after the third round. No reason to be watching those 20+ off the lead.

Through the eighth hole, not one birdie yet. And the hole locations have been changed in the players' favor. And it's warmer and less windy than yesterday.

The Liquidity Crisis -- A Major Theme -- 2022

From corporations to the middle classes (lower-, middle-, and upper-middle classes): a looming liquidity crisis.

Themes - 2022.

New theme added for 2022: the liquidity crisis.

Maybe one can trace it back to the Fed, but the tipping point for the Great Recession of 2022 will be "the liquidity crisis."

Exhibit A: wind energy plants in Kansas and Iowa are shutting down. I can't imagine a better time for renewable energy: high energy prices; strong back from Washington (DC); and, yet, this story:

HUTCHINSON, Kan. (AP) — Siemens Gamesa wind-energy plants in Hutchinson, Kansas, and Fort Madison, Iowa, will close down while the company waits for new orders. 
Officials with the company announced Friday that most employees at the two plants will be laid off. 
The blade manufacturing plant in Iowa will close in June, followed by the Kansas plant in July. 
Siemens said 171 people work at the Iowa plant, with 92 in Kansas. The company said it is possible the plants could reopen if market conditions improve. 
The Iowa plant manufactures wind turbine blades. The Kansas plant manufactures nacelles, which house the turbine’s generating components.

This will trickle down to high middle-income folks who were banking on their huge stock market gains to finance their expensive air fair and car rental vacations to the national parks in Colorado, Wyoming, and Montana. The upper middle class (maybe) and the upper class will do find but the middle middle class and below will struggle in the Great Recession of 2022. 

The Sports Page -- May 21, 2022

PGA: third round.

  • early, analyst on Tiger Wood's first five holes: "the ship is sinking."
    • an early bogey, then a triple bogey followed by a bogey
    • entered +3 at start of the third round; five holes in, now +8
    • ended the round at +12; 79, just barely missed shooting an 80

NASCAR: Texas Motor Speedway

  • early afternoon today
  • late evening Sunday night

NBA: Pretty much one game each day until the NBA Championship.

  • Miami Heat at Boston Celtics, best-of-seven series tied at 1-1.

Off the net for awhile.  

***************************
Poolside -- Luxury Hotel

Book: The Shores of Bohemia, A Cape Cod Story 1910 - 1960, John Taylor Williams, c. 2022. 

A must read for all of those heading to Cape Cod this summer. Hard copy now but soft cover soon, I assume.

Monkeypox -- May 21, 2022

A reader quickly noted that the "k" in monkeypox is silent. LOL.

The reader was correct. 

As a public health problem, monkeypox will be nowhere as severe as Covid-19 but it will cause much more alarm among parents and grandparents. 

I wasn't going to post this on the "Bakken blog" (I posted it elsewhere earlier) but thought some readers might be interested. 

The most interesting article for me? The September 24, 2019, FDA announcement (see below). 

The biggest question? How soon will the US military begin smallpox / monkeypox vaccinations again? Apparently, the Europeans are taking this seriously.

Stocks mentioned, action May 20, 2022:

  • Emergent BioSolutions Inc (EBS): up 12%; up $4; trading at $36
  • Chimerix, Inc (CMRX): up 7%, then up 13% after-hours; trading at $2.35 at the close; after-hours, $2.65. One could buy a lot of CMRX at $3 / share.
  • Bavarian Nordic A/S (BVNRY): up 4%; up 40 cents; trading at $11.

Disclaimer: this is not an investment site.  Do not make any investment, financial, job, career, travel, or relationship decisions based on what you read here or think you may have read here.

All my posts are done quickly: there will be content and typographical errors. If anything on any of my posts is important to you, go to the source. If/when I find typographical / content errors, I will correct them.

As monkeypox quickly spreads, a handful of biotechs spring into action, May 20, 2022. Link here.

Emergent Biosolutions’ stock jumped more than 10% on Friday, four days after the company plumped down $225 million for the rights to Chimerix’s smallpox vaccine
Chimerix’s stock was up more than 3.8% on Friday. And Bavarian Nordic $BVNRY — which closed a $119 million deal with BARDA to provide the US government with freeze-dried doses of the Jynneos vaccine — was up nearly 2.5%. 

FDA approves first live, non-replicating vaccine to prevent smallpox and monkeypox, September 24, 2019. Link here

The FDA granted the approval of Jynneos to Bavarian Nordic A/S. The FDA granted the application Priority Review and with this approval, the FDA issued a material threat medical countermeasure (MCM) priority review voucher to Bavarian Nordic A/S
The Federal Food, Drug, and Cosmetic Act, as amended by the 21st Century Cures (Cures) Act, authorizes the FDA to award priority review vouchers to sponsors of approved material threat MCM product applications that meet certain criteria.

Emergent to buy Sanofi smallpox vaccine and take on CDC contract, July 18, 2017. Link here.

Smallpox vaccine, what you need to know, New York Health, April, 2003.

Scientific American, March 3, 2003. Link here.

There are two types of smallpox vaccine that would be administered in the event of an outbreak in the U.S. Both vaccines use the same strain of vaccinia virus, the so-called New York Board of Health strain, and they differ only in the way they are prepared. 
The old Dryvax vaccine, made in the 1970s by Wyeth Laboratories, was made by purifying vaccinia virus obtained from pustules removed from deliberately infected cows. The vaccine currently produced by Acambis-Baxter Laboratories is made using modern tissue-culture methods: the vaccinia is grown in cells in a laboratory and then purified. 
See FDA announcement, 2019, above.